- Press Releases
- Notices
Press Releases To List
-
- Mar.27.2024Corporate
- Ono Announces General Sponsorship for the “Theme Weeks” as Bronze Partner, at the Expo 2025 Osaka, Kansai, Japan
-
- Mar.22.2024Licensing
- Ono Enters into Comprehensive Drug Discovery Collaboration Agreement with University of Oxford
-
- Mar.21.2024R & D
- ONO PHARMA Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL
-
- Mar.21.2024R & D
- Bristol Myers Squibb Announces CheckMate -9DW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Meets Primary Endpoint of Overall Survival for the First-Line Treatment of Advanced Hepatocellular Carcinoma
-
- Mar.14.2024Licensing
- Ono Enters into a Collaboration Agreement with Sibylla Biotech to Generate Novel Drug Candidates for Neurological Disorders
Notices To List
-
- Sep.26.2023Corporate
- Corporate Report 2023 has been released.
-
- Jun.23.2023Corporate
- Voting Results (Extraordinary Report) of the 75th Ordinary General Shareholders’ Meeting
-
- Jun.22.2023Corporate
- Notice to Resolutions Passed at The 75th Ordinary General shareholders’ Meeting
-
- May.25.2023Corporate
- Notice to Convene the 75th Ordinary General Shareholders' Meeting
-
- Sep.22.2022Corporate
- Announcement on posting of Corporate Report 2022
About
We Want to Deliver New Drugs
to the World with a Wish.
For more than 300 years since its foundation in 1717, working for people’s health.
Diseases still unconquered. Patients' wishes still unfulfilled.
ONO, with a wish to meet these medical needs, devotes all its efforts to drug discovery.